Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenzhuo He

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Aging|December 31, 2018
Comparisons of metastatic patterns of colorectal cancer among patients by age group: a population-based studyLin Yang, Xingli Yang, Wenzhuo He, et al.
Medical Oncology (Northwood, London, England)|January 12, 2013
Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancerWenzhuo He, Chenxi Yin, Guifang Guo, et al.
Frontiers in Medicine|February 10, 2025
Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancerLei Wang, Yafei You, Wenzhuo He, et al.
Clinical Breast Cancer|October 3, 2012
Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancerFang Wang, Wenzhuo He, Huijuan Qiu, et al.
BMC Medicine|October 5, 2020
Adipose tissue area as a predictor for the efficacy of apatinib in platinum-resistant ovarian cancer: an exploratory imaging biomarker analysis of the AEROC trialXin Huang, Chuanbo Xie, Jie Tang, et al.
Oncotargets and Therapy|November 26, 2015
A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-CFangxin Liao, Wenzhuo He, Chang Jiang, et al.
Scientific Reports|July 25, 2020
First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective studyShousheng Liu, Chang Jiang, Lin Yang, et al.
Oncotargets and Therapy|August 22, 2014
Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancerChenxi Yin, Chang Jiang, Fangxin Liao, et al.
Oncology Letters|January 25, 2019
Tumor microenvironment classification based on T-cell infiltration and PD-L1 in patients with mismatch repair-proficient and -deficient colorectal cancerShousheng Liu, Pengfei Kong, Xiaopai Wang, et al.
Scientific Reports|July 7, 2016
Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric CancerPengfei Kong, Ruiyan Wu, Chenlu Yang, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Aging|December 31, 2018
Comparisons of metastatic patterns of colorectal cancer among patients by age group: a population-based studyLin Yang, Xingli Yang, Wenzhuo He, et al.
Medical Oncology (Northwood, London, England)|January 12, 2013
Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancerWenzhuo He, Chenxi Yin, Guifang Guo, et al.
Frontiers in Medicine|February 10, 2025
Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancerLei Wang, Yafei You, Wenzhuo He, et al.
Clinical Breast Cancer|October 3, 2012
Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancerFang Wang, Wenzhuo He, Huijuan Qiu, et al.
BMC Medicine|October 5, 2020
Adipose tissue area as a predictor for the efficacy of apatinib in platinum-resistant ovarian cancer: an exploratory imaging biomarker analysis of the AEROC trialXin Huang, Chuanbo Xie, Jie Tang, et al.
Oncotargets and Therapy|November 26, 2015
A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-CFangxin Liao, Wenzhuo He, Chang Jiang, et al.
Scientific Reports|July 25, 2020
First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective studyShousheng Liu, Chang Jiang, Lin Yang, et al.
Oncotargets and Therapy|August 22, 2014
Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancerChenxi Yin, Chang Jiang, Fangxin Liao, et al.
Oncology Letters|January 25, 2019
Tumor microenvironment classification based on T-cell infiltration and PD-L1 in patients with mismatch repair-proficient and -deficient colorectal cancerShousheng Liu, Pengfei Kong, Xiaopai Wang, et al.
Scientific Reports|July 7, 2016
Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric CancerPengfei Kong, Ruiyan Wu, Chenlu Yang, et al.
Pageof 5